Menu

Experience

Tom Coll

    • Arlo to Partner with Verisure 


    • Castle Biosciences $74 Million IPO 


    • Equillium – $65.4 Million IPO 


    • Dot Hill Systems sale to Seagate Technology 


    • Cooley Advises Xencor on its Initial Public Offering 


    • Ambit Biosciences to be Acquired by Daiichi Sankyo for $410 Million 


    • Vital Therapies Initial Public Offering 


    • Cooley Advises Underwriters on Vital Therapies IPO 


    • Flexion $74 Million Initial Public Offering 


    • Cooley Advised Flexion on Initial Public Offering 


    • Xencor Initial Public Offering 


    • Ambit Initial Public Offering 


    • Receptos, Inc. Initial Public Offering 


    • Cooley Advises Ambit on its IPO 


    • Suneva Medical Financing 


    • Bionano Genomics Initial Public Offering 


    • Mirati – $1.0 Billion Follow-On Offering